ABNB vs BKNG vs RCL
161 measures in 16 categories, one definition each, computed from filings and market data.
BKNG77.0
Booking Holdings Inc.
Consumer Cyclical · Travel Services
$163.45 −1.42%$122.8B mkt cap
Score DNA
RCL54.4
Royal Caribbean Cruises Ltd.
Consumer Cyclical · Travel Services
$277.62 −0.85%$74.3B mkt cap
Score DNA
Price, rebased to 100 three years ago
ABNB BKNG RCL · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | ABNB | BKNG | RCL |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 0 | 2 | 3 |
| Last Congress purchase | — | 2026-07-07 | 2026-07-07 |
| 13F net change in holders | +13 | +17 | +56 |
| ETFs adding shares, 30d | 1,294 | 1,632 | 466 |
| ETFs trimming, 30d | 1,035 | 1,395 | 293 |
| Net ETF funds, 30d | +259 | +237 | +173 |
Valuation
16 measures| Measure | ABNB | BKNG | RCL |
|---|---|---|---|
| P/E (TTM) | 38.7x
70th
|
17.0x
50th
|
16.9x
40th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 4.18 | — | — |
| Price / sales | 7.9x
100th
|
4.3x
82nd
|
4.0x
64th
|
| Price / book | 13.3x
71st
|
— | 7.3x
57th
|
| Price / tangible book | 12.1x
80th
|
— | 9.1x
60th
|
| Price / free cash flow | 21.4x
75th
|
12.9x
50th
|
— |
| Price / operating cash flow | 21.4x
91st
|
12.5x
55th
|
10.9x
45th
|
| Enterprise value | $94.4B
82nd
|
$126.3B
100th
|
$96.9B
91st
|
| EV / sales | 7.2x
100th
|
4.5x
64th
|
5.2x
82nd
|
| EV / EBITDA | 33.8x
100th
|
11.7x
36th
|
13.4x
55th
|
| EV / EBIT | 34.5x
91st
|
12.5x
18th
|
17.6x
55th
|
| EV / free cash flow | 19.4x
62nd
|
13.2x
25th
|
— |
| Earnings yield | 2.6%
36th
|
5.9%
55th
|
5.9%
64th
|
| FCF yield | 4.7%
45th
|
7.8%
64th
|
-0.6%
9th
|
| Operating cash flow yield | 4.7%
9th
|
8.0%
45th
|
9.1%
55th
|
| Graham number (per share) | $36.40
71st
|
— | $117.93
100th
|
Profitability (TTM)
12 measures| Measure | ABNB | BKNG | RCL |
|---|---|---|---|
| Gross margin | 78.0%
82nd
|
100.0%
100th
|
46.6%
55th
|
| EBITDA margin | 21.3%
36th
|
38.2%
91st
|
38.6%
100th
|
| Operating margin | 20.8%
73rd
|
34.5%
100th
|
27.3%
91st
|
| EBIT margin | 20.8%
73rd
|
35.9%
100th
|
29.5%
91st
|
| Net margin | 20.4%
82nd
|
25.5%
100th
|
23.6%
91st
|
| NOPAT margin | 16.6%
73rd
|
26.8%
91st
|
27.0%
100th
|
| FCF margin | 37.0%
100th
|
33.8%
91st
|
-2.2%
9th
|
| Operating cash flow margin | 36.9%
100th
|
34.9%
73rd
|
36.3%
91st
|
| R&D / revenue | 18.9%
100th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 32.7%
73rd
|
59.3%
100th
|
12.0%
0th
|
| Stock comp / revenue | 13.0%
100th
|
2.1%
82nd
|
0.8%
18th
|
| Effective tax rate | 20.0%
36th
|
22.4%
55th
|
1.2%
9th
|
Returns on capital
11 measures| Measure | ABNB | BKNG | RCL |
|---|---|---|---|
| ROE (on average equity) | 34.5%
43rd
|
— | 45.4%
71st
|
| ROA | 9.7%
73rd
|
23.9%
100th
|
10.6%
82nd
|
| ROIC | -123.5%
9th
|
-103.5%
18th
|
15.3%
73rd
|
| ROCE | 25.7%
82nd
|
117.7%
100th
|
16.7%
64th
|
| Return on tangible assets | 9.8%
64th
|
33.6%
100th
|
13.2%
82nd
|
| Cash ROIC (OCF / invested capital) | — | — | 20.6%
50th
|
| Gross profitability (GP / assets) | 36.8%
64th
|
95.1%
100th
|
19.5%
27th
|
| ROIC, 3-yr average | — | — | 12.4%
71st
|
| ROIC, 5-yr average | — | — | 3.8%
75th
|
| ROE, 5-yr average | 39.6%
80th
|
— | -1.9%
40th
|
| Incremental ROIC | 38.8%
73rd
|
-157.9%
27th
|
30.6%
64th
|
Growth
17 measures| Measure | ABNB | BKNG | RCL |
|---|---|---|---|
| Revenue growth (TTM YoY) | 13.6%
80th
|
12.9%
70th
|
8.7%
50th
|
| Revenue growth (QoQ) | 34.7%
82nd
|
32.9%
73rd
|
8.5%
9th
|
| Revenue CAGR, 3 yr | 13.1%
56th
|
13.4%
67th
|
15.9%
78th
|
| Revenue CAGR, 5 yr | 33.7%
44th
|
31.5%
33rd
|
188.6%
89th
|
| Gross profit CAGR, 3 yr | 12.3%
44th
|
13.4%
56th
|
24.6%
89th
|
| Operating income CAGR, 3 yr | 11.9%
29th
|
17.2%
43rd
|
55.5%
71st
|
| Net income growth (TTM YoY) | 2.5%
40th
|
49.8%
80th
|
22.2%
70th
|
| Net income CAGR, 3 yr | 5.4%
25th
|
17.4%
50th
|
— |
| EPS growth (TTM YoY) | 7.5%
60th
|
-93.7%
0th
|
24.4%
80th
|
| EPS CAGR, 3 yr | 9.2%
50th
|
-57.3%
0th
|
— |
| EPS CAGR, 5 yr | — | -1.5% | — |
| FCF growth (TTM YoY) | 13.6%
50th
|
3.2%
25th
|
— |
| FCF CAGR, 3 yr | 7.7%
20th
|
13.9%
60th
|
— |
| Operating cash flow CAGR, 3 yr | 7.4%
25th
|
13.2%
38th
|
28.0%
62nd
|
| Book value CAGR, 3 yr | 19.7%
40th
|
— | 47.0%
80th
|
| Dividend CAGR, 3 yr | — | -63.0% | 10.6% |
| Sustainable growth rate | 34.5%
43rd
|
— | 39.3%
71st
|
Margin history & stability
7 measures| Measure | ABNB | BKNG | RCL |
|---|---|---|---|
| Gross margin, 3-yr average | 82.1%
70th
|
100.0%
100th
|
47.2%
40th
|
| Operating margin, 3-yr average | 19.5%
70th
|
31.9%
100th
|
25.9%
90th
|
| Net margin, 3-yr average | 29.7%
100th
|
22.4%
90th
|
20.3%
80th
|
| FCF margin, 3-yr average | 38.6%
100th
|
34.7%
90th
|
5.0%
10th
|
| Revenue stability (0-1) | 0.95
80th
|
0.96
90th
|
0.92
60th
|
| Earnings stability (0-1) | 0.51
20th
|
0.90
60th
|
0.93
90th
|
| Margin stability (0-1) | 0.96
70th
|
1.00
100th
|
0.00
0th
|
Liquidity (latest quarter)
7 measures| Measure | ABNB | BKNG | RCL |
|---|---|---|---|
| Cash & short-term investments | $12.1B
91st
|
$17.2B
100th
|
$875.0M
55th
|
| Net cash (− = net debt) | $9.6B
100th
|
−$3.5B
36th
|
−$22.6B
9th
|
| Working capital | $7.4B
100th
|
$2.0B
82nd
|
−$9.2B
0th
|
| Current ratio | 1.41
64th
|
1.09
55th
|
0.21
9th
|
| Quick ratio | 1.41
64th
|
1.09
55th
|
0.19
9th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.67
73rd
|
0.82
82nd
|
0.08
9th
|
| Defensive interval (days) | 571 days
73rd
|
425 days
55th
|
133 days
9th
|
Leverage & solvency (latest quarter)
13 measures| Measure | ABNB | BKNG | RCL |
|---|---|---|---|
| Total debt | $2.5B
36th
|
$20.7B
82nd
|
$23.5B
91st
|
| Debt / equity | 0.32
0th
|
— | 2.30
57th
|
| Net debt / equity | −1.23
0th
|
— | 2.21
86th
|
| Debt / assets | 8.7%
0th
|
69.7%
82nd
|
52.7%
55th
|
| Debt / capital | 24.2%
0th
|
— | 69.7%
57th
|
| Debt / EBITDA | 0.89
0th
|
1.92
18th
|
3.26
45th
|
| Net debt / EBITDA | −3.42
0th
|
0.32
27th
|
3.14
55th
|
| Interest coverage (EBIT / interest) | 74.0x
100th
|
9.2x
91st
|
5.4x
64th
|
| Cash interest coverage | 131.4x
100th
|
8.9x
82nd
|
6.6x
55th
|
| Debt payback (years of OCF) | 0.5 yrs
0th
|
2.1 yrs
18th
|
3.5 yrs
45th
|
| Liabilities / assets | 72.9%
18th
|
136.3%
100th
|
76.6%
36th
|
| IS credit model rating | AA | AA- | BB+ |
| Implied credit spread (bps) | 80
0th
|
100
9th
|
400
45th
|
Efficiency
11 measures| Measure | ABNB | BKNG | RCL |
|---|---|---|---|
| Asset turnover | 0.47
27th
|
0.94
100th
|
0.45
18th
|
| Fixed asset turnover | — | 20.75
90th
|
0.48
0th
|
| Inventory turnover | — | — | 38.8
67th
|
| Receivables turnover | 66.6
100th
|
6.5
20th
|
42.8
80th
|
| Days sales outstanding | 5 days
9th
|
56 days
82nd
|
9 days
27th
|
| Days inventory outstanding | — | — | 9 days
33rd
|
| Days payables outstanding | 26 days
40th
|
— | 38 days
70th
|
| Cash conversion cycle (days) | −20 days
30th
|
— | −20 days
40th
|
| Capex / revenue | — | 1.1%
10th
|
38.6%
100th
|
| Capex / depreciation | — | 0.49
20th
|
4.21
90th
|
| Operating expense ratio | 61.4%
73rd
|
66.0%
82nd
|
20.2%
18th
|
Cash flow & earnings quality
7 measures| Measure | ABNB | BKNG | RCL |
|---|---|---|---|
| Operating cash flow / net income | 1.81
20th
|
1.37
0th
|
1.54
10th
|
| FCF / net income | 1.81
60th
|
1.32
50th
|
−0.09
20th
|
| FCF / operating cash flow | — | 96.8%
100th
|
-6.1%
20th
|
| Capex / operating cash flow | — | 3.2%
0th
|
106.1%
80th
|
| Accruals ratio | -7.8%
45th
|
-8.8%
36th
|
-5.7%
82nd
|
| Sloan accruals ratio | 10.6%
100th
|
-10.9%
0th
|
-6.8%
18th
|
| Earnings quality score (0-1) | 0.75
0th
|
0.75
0th
|
0.75
0th
|
Scores & forensic checks
15 measures| Measure | ABNB | BKNG | RCL |
|---|---|---|---|
| IS score | 75
91st
|
77
100th
|
54
64th
|
| IS profitability | 80
91st
|
80
82nd
|
80
73rd
|
| IS growth | 54
50th
|
78
80th
|
66
70th
|
| IS value | 29
9th
|
50
64th
|
47
55th
|
| IS momentum | 80
50th
|
93
90th
|
89
70th
|
| IS risk (safety) | 80
73rd
|
100
100th
|
50
55th
|
| IS quality | 87
100th
|
73
82nd
|
70
64th
|
| IS balance sheet | 81
100th
|
59
82nd
|
29
18th
|
| IS earnings quality | 83
64th
|
67
27th
|
86
91st
|
| IS cash flow | 94
91st
|
80
82nd
|
25
0th
|
| Piotroski F-score (0-9) | 7
55th
|
5
0th
|
6
18th
|
| Altman Z-score | 3.2
91st
|
6.2
100th
|
2.3
64th
|
| Beneish M-score | −3.63
0th
|
−2.95
36th
|
−2.65
82nd
|
| Ohlson O-score | −7.69
0th
|
−5.79
64th
|
−6.67
27th
|
| IS credit score | 90
100th
|
83
91st
|
47
55th
|
Size (TTM)
8 measures| Measure | ABNB | BKNG | RCL |
|---|---|---|---|
| Market cap | $104.0B
91st
|
$122.8B
100th
|
$74.3B
82nd
|
| Revenue | $13.2B
64th
|
$28.2B
100th
|
$18.7B
82nd
|
| EBITDA | $2.8B
64th
|
$10.8B
100th
|
$7.2B
82nd
|
| Net income | $2.7B
73rd
|
$7.2B
100th
|
$4.4B
91st
|
| Free cash flow | $4.9B
82nd
|
$9.5B
100th
|
−$416.0M
9th
|
| Total assets | $28.8B
64th
|
$29.7B
82nd
|
$44.6B
91st
|
| Shareholders' equity | $7.8B
82nd
|
−$10.8B
0th
|
$10.2B
91st
|
| Employees | 8,200
36th
|
25,550
73rd
|
107,975
91st
|
Price performance
9 measures| Measure | ABNB | BKNG | RCL |
|---|---|---|---|
| 1 day | −0.3% | −1.4% | −0.8% |
| 1 week | +4.7% | +1.9% | −1.6% |
| 1 month | +4.7% | −4.2% | +11.2% |
| 3 months | +19.8% | −8.7% | −3.0% |
| 6 months | +22.7% | −14.5% | −2.8% |
| Year to date | +30.6% | −22.7% | −2.0% |
| 1 year | +39.8% | −18.8% | −10.8% |
| 3 years, cumulative | +33.6% | +36.2% | +215.6% |
| 5 years, cumulative | +2.2% | +69.1% | +220.9% |
Technicals
4 measures| Measure | ABNB | BKNG | RCL |
|---|---|---|---|
| RSI 14 | 60.9 | 45.2 | 54.9 |
| From 52-week high | −10.2% | −25.4% | −22.1% |
| From 52-week low | +56.8% | +9.4% | +24.9% |
| Beta | 1.24 | 1.13 | 1.82 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17